Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy

Chiu, Chiung-YiChiung-YiChiuHuang, Tzu-LunTzu-LunHuangChang, Pei-YaoPei-YaoChangChen, Fang-TingFang-TingChenHsu, Yung-RayYung-RayHsuChen, Yun-JuYun-JuChenJIA-KANG WANG2024-01-202024-01-20202122115056https://scholars.lib.ntu.edu.tw/handle/123456789/638661The purpose of this study is to compare the efficacy of intravitreal ranibizumab (IVR) alone and concurrent IVR with posterior subtenon triamcinolone acetonide (PSTA) injection for patients with diabetic macular edema (DME) refractory to IVR monotherapy.enIntravitreal ranibizumab; posterior subtenon triamcinolone acetonide; refractory diabetic macular edemaCombined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapyjournal article10.4103/tjo.tjo_31_20347037402-s2.0-85115063863https://api.elsevier.com/content/abstract/scopus_id/85115063863